# Agnitio Inc – FDA Inspection, Aug 7, 2026

Source: https://www.keypedia.com/records/fda_inspections/agnitio-inc/5670a71a-994c-4cf1-9bc2-adbe8f1e2f99
Source feed: FDA_Inspections

> FDA inspection 1332380 of Agnitio Inc, August 07, 2026. 2 citations under 21 CFR part 314. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1332380
- Company Name: Agnitio Inc
- Inspection Date: 2026-08-07
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Minneapolis District Office
- Citation Count: 2

## Related Documents

- FDA Inspection 1295362 - 2025-11-21
- [FDA Inspection 1146649 - 2021-06-04](https://www.keypedia.com/records/fda_inspections/agnitio-inc/d19d5009-9492-4a21-8033-cd779e5d70df)
- [FDA Inspection 1071299 - 2018-11-09](https://www.keypedia.com/records/fda_inspections/agnitio-inc/2c56e945-ad0b-4c2a-bbd0-ff49e367246e)
- [FDA Inspection 1059372 - 2018-07-19](https://www.keypedia.com/records/fda_inspections/agnitio-inc/6afe22f8-1834-4baa-815d-6577357bb3f8)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/stephen-o-agyemang/b420a55d-21ea-46c7-8400-a8f22ca9b423)

Company: https://www.keypedia.com/companies/agnitio-inc/6bcd09b9-e002-45bf-805c-0e4474b1bdfb

Office: https://www.keypedia.com/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d